Neurocrine Bio (NBIX) Posts Q4 Loss of $0.20, Better by 7c

February 3, 2010 4:26 PM EST Send to a Friend

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reports Q4 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Neurocrine Bio (NBIX) Posts Q4 Loss of $0.20, Better by 7c

Member Login

Free News Feed